Progress on Hepatitis C, but many don’t know they have it

Check out the great op-ed by my friend and colleague, Dr. Charlie Van der Horst. “With an expectant smile and raised eyebrows, my patient watched me enter the exam room. Dressed in slacks with a straight crease and neat shirt, he was looking for an answer…” Read more here: Continue reading Progress on Hepatitis C, but many don’t know they have it

Arthur Kim’s morning lecture

Today’s morning lecture at MGH by Dr. Arthur Kim was about HBV/HCV. A few take-home points: Hepatitis B’s geographic distribution is important. The highest prevalence settings include Asia and Sub-Saharan Africa, even though quality of surveillance data is often an issue. Vaccination, vaccination, vaccination for HBV! Normal ALT does not mean there is no liver disease. Entecavir (HBV treatment) has anti-HIV activity and can lead … Continue reading Arthur Kim’s morning lecture

Hepatitis C and Kidney Disease

This evening from 6-8 PM at the Mass General was a nice interdisciplinary symposium regarding Hepatitis C with a particular focus on kidney disease. The session was organized by Dr. Meghan Sise, a MGH nephrologist. The attendees included nephrologists, hepatologists, ID doctors, and surgeons. A few highlights: Jai Radhakrishnan from Columbia University explained that HCV is most often associated with immune-mediated cryoglobulinemic vasculitis and MPGN Raymond Chung from MGH spoke about the … Continue reading Hepatitis C and Kidney Disease